Samer Kaylani, M.D.

Pediatrics - Hematology-Oncology

Biography

Samer Zaid Kaylani, M.D., is a Clinical Associate Professor in the Department of Pediatrics at UT Southwestern Medical Center.

Dr. Kaylani earned his medical degree at the Jordan University of Science and Technology Faculty of Medicine. He completed a residency in pediatrics at the Texas Tech University Health Sciences Center and received advanced training through a pediatric hematology/oncology fellowship at the University of Alabama at Birmingham.

Certified by the American Board of Pediatrics in pediatric hematology-oncology, Dr. Kaylani joined the UT Southwestern faculty in 2023.

Dr. Kaylani is a Fellow of the American Academy of Pediatrics and a member of several professional organizations, including the American Society of Hematology, the American Society of Pediatric Hematology-Oncology, and the Dallas County Medical Society.

Education & Training

Fellowship - University of Alabama at Birmingham (2010-2013), Pediatric Hematology/oncology
Residency - Texas Tech Health Sciences Center in Amarillo (2007-2010), Pediatrics
Medical School - Jordan University of Science and Technology Faculty of Medicine, Jordan (2000-2006)

Professional Associations & Affiliations

American Academy of Pediatrics
American Society of Hematology
American Society of Pediatric Hematology-Oncology
Dallas County Medical Society
Jordan Medical Association
Texas Medical Association

Honors & Awards

Resident Teacher Award 2024, UT Southwestern Residency Program
Fellow Teacher Award 2024, George Buchanan, M.D., UT Southwestern
Unsung Hero Award 2022, Regional Dean Award, Texas Tech University
Texans Taking Care of Texans Award 2021, Texas State Department

Books & Publications

Publications
- How do we manage hyperhemolysis syndrome.
  Adkins BD, Kaylani SZ, Nero A, Ibrahim IF, Shen YM, Sarode R, Transfusion 2024 Oct 64 10 1822-1829
- Head Lice Infestation: An Unusual Cause of Iron Deficiency Anemia in a 13-Year-Old Female.
  Ogbuji CO, Schuck A, DeVries M, Majdinasab EJ, Benson K, Zaid-Kaylani S, Bhaskaran S, Cureus 2022 Jun 14 6 e25956
- REFRACTORY IMMUNE THROMBOCYTOPENIA WITH SUSPECTED EVANS SYNDROME REQUIRING QUADRUPLE THERAPY
  Bewaji O, Kandaswamy , Maniam G , Bhaskaran S , Zaid-Kaylani S Journal of Rare Diseases and Orphan Drugs, V1, 2020 2020
- National Trends in Hospitalization for Fever and Neutropenia in Children with Cancer, 2007-2014.
  Lekshminarayanan A, Bhatt P, Linga VG, Chaudhari R, Zhu B, Dave M, Donda K, Savani S, Patel SV, Billimoria ZC, Bhaskaran S, Zaid-Kaylani S, Dapaah-Siakwan F, Bhatt NS, The Journal of pediatrics 2018 Nov 202 231-237.e3
- Temporal trends of splenectomy in pediatric hospitalizations with immune thrombocytopenia.
  Bhatt NS, Bhatt P, Donda K, Dapaah-Siakwan F, Chaudhari R, Linga VG, Patel B, Lekshminarayanan A, Bhaskaran S, Zaid-Kaylani S, Badawy SM, Pediatric blood & cancer 2018 Jul 65 7 e27072
- A 14-year-old boy with extranodal natural killer cell lymphoma of the nose, nasopharynx, larynx, and trachea in remission 6years after primary diagnosis. A longitudinal case report.
  Gungor A, Pennington L, Sankararaman S, Zaid-Kaylani S, Jeroudi MA, American journal of otolaryngology 2016 37 6 563-566
- GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.
  Srivastava RK, Kaylani SZ, Edrees N, Li C, Talwelkar SS, Xu J, Palle K, Pressey JG, Athar M Oncotarget 2014 Oct
- Rapamycin targeting mTOR and hedgehog signaling pathways blocks human rhabdomyosarcoma growth in xenograft murine model.
  Kaylani SZ, Xu J, Srivastava RK, Kopelovich L, Pressey JG, Athar M, Biochemical and biophysical research communications 2013 Jun 435 4 557-61
- Treatment of infantile hemangiomas with sirolimus in a patient with PHACE syndrome.
  Kaylani S, Theos AJ, Pressey JG, Pediatric dermatology 2013 30 6 e194-7